NEU 2.38% $12.70 neuren pharmaceuticals limited

Acadia, page-803

  1. 110 Posts.
    lightbulb Created with Sketch. 70
    Not sure why ppl keep repeating that Ph3 will cost $300M USD. JP has said he believes it will cost a lot less than that, and that Neuren could afford to conduct 2 Ph3 trials.

    "then I see no point."

    It's not rocket science. The point is BP is going to pay more for companies with pipelines that are closer to commercialisation.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.